Chenchula Santenna, Sadasivam Balakrishnan, Shukla Ajay, Pathan Saman
Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal, India.
Department of Anaesthesiology & Intensive care, All India Institute of Medical Sciences Bhopal, Bhopal, India.
J Infect Prev. 2023 Jul;24(4):159-165. doi: 10.1177/17571774231161821. Epub 2023 Mar 10.
The present study was conducted to study the prevalence of HAIs in a newly established MICU, common microorganisms causing HAIs and their antibiotic-sensitivity profile, and antimicrobial utilization and mortality rate.
The present retrospective cohort study was carried out at AIIMS, Bhopal (2015-2019). The prevalence of HAIs was determined; sites of HAIs and common causative microorganisms were identified, and their antibiotic-sensitivity profiles were studied. The group of patients with HAIs was matched with a control group drawn from the pool of patients without HAIs; this matching was done with respect to age, gender, and clinical diagnosis. Antimicrobial utilization, Period of ICU stay, comorbidities and patient mortality rates in the two groups were analyzed. The clinical criteria by the CDC- National Nosocomial Infections Surveillance to diagnose HAIs.
A total of 281 ICU patients' records were analyzed. The mean age was 47.21 ± 19.07 years. Of these 89 were found to have developed ICU-acquired HAIs (Prevalance:32%). Bloodstream infections (33%) and respiratory tract infections (30.68%), catheter-associated urinary tract infections (25.56%), and surgical site infections (6.76%) were the commonest. The most frequently isolated microorganism causing HAIs was K. pneumonia (18%), A. baumannii (14%) and (12%), 31% isolates of which were multidrug resistant. The average length of ICU stay was high in patients with HAIs (13.85 vs 8.2 days). The most common co-morbidity was type 2 diabetes mellitus (42.86%). Prolonged ICU stays [OR 1.13, (95% CI; 0.04-0.10)] and the presence of HAIs [OR 1.18(95%CI; (0.03-0.15)] were associated with an increased risk of mortality.
An increased prevalence of HAIs essentially bloodstream infections and respiratory infections with MDR organisms to antimicrobials in the watch group is highly considerable. Acquisition of HAIs with MDR organisms and increased length of hospital stay are considerable risk factors for increased mortality in ICU-admitted patients. Regular antimicrobial stewardship activities and revising existing hospital infection control policies accordingly may reduce HAIs.
本研究旨在调查新建重症医学监护病房(MICU)中医院获得性感染(HAIs)的患病率、引起HAIs的常见微生物及其抗生素敏感性谱,以及抗菌药物使用情况和死亡率。
本回顾性队列研究在博帕尔全印医学科学研究所(2015 - 2019年)进行。确定HAIs的患病率;确定HAIs的发生部位和常见致病微生物,并研究其抗生素敏感性谱。将发生HAIs的患者组与从无HAIs的患者群体中抽取的对照组进行匹配;这种匹配是在年龄、性别和临床诊断方面进行的。分析两组患者的抗菌药物使用情况、重症监护病房住院时间、合并症和患者死亡率。采用美国疾病控制与预防中心国家医院感染监测的临床标准来诊断HAIs。
共分析了281例重症监护病房患者的记录。平均年龄为47.21±19.07岁。其中89例被发现发生了重症监护病房获得性HAIs(患病率:32%)。血流感染(33%)和呼吸道感染(30.68%)、导管相关尿路感染(25.56%)以及手术部位感染(6.76%)最为常见。引起HAIs最常分离出的微生物是肺炎克雷伯菌(18%)、鲍曼不动杆菌(14%)和[此处原文缺失一种微生物名称](12%),其中31%的分离株对多种药物耐药。发生HAIs的患者重症监护病房平均住院时间较长(13.85天对8.2天)。最常见的合并症是2型糖尿病(42.86%)。重症监护病房住院时间延长[比值比1.13,(95%置信区间;0.04 - 0.10)]和发生HAIs[比值比1.18(95%置信区间;(0.03 - 0.15)]与死亡风险增加相关。
在观察组中,HAIs尤其是血流感染和呼吸道感染以及多重耐药菌感染的患病率增加情况非常值得关注。获得多重耐药菌引起的HAIs以及住院时间延长是重症监护病房收治患者死亡率增加的重要危险因素。定期开展抗菌药物管理活动并相应修订现有的医院感染控制政策可能会减少HAIs。